ABSTRACTS from 16th International COnference on ... - CRRT Online

More documents

Recommendations

Info

<strong>ABSTRACTS</strong> FROM 17 TH INTERNATIONAL CONFERENCE ON CRRT, SAN DIEGO, FEB 14-17, 2012 3.88 vs 0.8 + 1.5 p
<strong>ABSTRACTS</strong> FROM 17 TH INTERNATIONAL CONFERENCE ON CRRT, SAN DIEGO, FEB 14-17, 2012 who were sequentially admitted to the intensive care unit. We used weaning of mechanical ventilation during the 28-day period as the endpoints. The follow-up of patients were performed until when the patient weaned <strong>from</strong> mechanical ventilation for the first time or the patient died during the 28-day period. After clinical data were obtained, the patients were underwent mtDNA haplotyping. We determined the mtDNA haplpgroups by comprehensive analyzing to the sequences of mtDNA hypervariable segment Ⅰ(HVSⅠ) and haplotyping specific polymorphisms in the mtDNA coding region. Results: Auunivariate analysis indicated that weaning individuals were significantly different <strong>from</strong> non-weaning ones <strong>from</strong> some demographic and clinical characteristics, including younger age, lower APACHEⅡ and SOFA score, less likely to have chronic ill health. On admission to intensive care unit, the frequency of the main subhaplogroups of Han population in the study cohort did not differ significantly <strong>from</strong> the control group. Kaplan-Meier analysis showed significantly higher mechanical ventilation weaning rate over 28 days in patients with mtDNA haplogroup R than those without the haplogroup (p=0.042). Binary logistic regression analysis indicated mtDNA haplogroup R was an independent predictor of mechanical ventilation weaning, cofferring 4.038- fold (p=0.007) increased chance of mechanical ventilation weaning at 28 days compared with those without the haplogroup. Conclusion: In Han population, mtDNA haplogroup R was an independent predictor for the weaning <strong>from</strong> mechanical ventilation of critically ill patients, conferring increased chance of weaning rate compared with individuals without the haplogroup. TECHNIQUE CHARACTERISTICS 59. A Comparison of Filter Patency in CVVHD vs pre–dilutional CVVH in High Blood Flow CRRT Systems Gaurav Agarwal, Anna M Brunson, Brad C Astor, A Djamali, R M HofmannDepartment of Medicine, University of Wisconsin School of Medicine and Public Health. Division of Nephrology. Madison, WI, USA , Acute Dialysis Services, University of Wisconsin Hospitals and Clinics, Madison WI, US Background: It is unknown if pre-filter replacement fluids decrease clotting versus diffusive therapies due to hemodilution effect in high blood flow continuous renal replacement (CRRT) era. National shortages of calcium injectables forced us to abandon regional citrate anticoagulation for CRRT. We wanted to determine if predilution continuous venovenous hemofiltration (CVVH) offered an advantage over continuous venovenous hemodialysis (CVVHD) for filter patency. Methods- We gathered data pertaining to all patients who received CRRT without any anticoagulation in the last 8 months. We compared filter life in the 2 groups – CVVH with pre dilution replacement fluid (group 1) vs CVVHD (group 2). All patients were run on the NxStage system one with a blood flow of 25 ml/min. 2 ml saline flushes were administered hourly to evaluate for filter patency. In group one, replacement fluids were started at 3 liters/hr and adjusted clinically. In group 2, dialysate was run at 25 ml/kg/hr and adjusted 168
Page 2 and 3:
CRRT 2012 SEVENTEENTH INTERNATIONAL
Page 4 and 5:
FACULTY DISCLOSURES CRRT 2012 Facul
Page 6 and 7:
CRRT 2012 ORGANIZING COMMITTEE USA
Page 8 and 9:
CRRT 2012 FACULTY Patrick Honoré,
Page 10 and 11:
ACKNOWLEDGEMENTS CRRT 2012 ACKNOWLE
Page 12 and 13:
PLENARY SESSIONS CRRT 2012 PROGRAM/
Page 14 and 15:
Page 16 and 17:
Page 18 and 19:
WORKSHOPS CRRT 2012 PROGRAM/INDEX T
Page 20 and 21:
WORKSHOPS CRRT 2012 PROGRAM/INDEX W
Page 22 and 23:
POSTER ABSTRACTS C
Page 24 and 25:
POSTER ABSTRACTS C
Page 26 and 27:
NURSING FORUM LUNCHEON Communicatio
Page 28 and 29:
Nutritional Support in ICU Patients
Page 30 and 31:
Educational Objectives: The Endothe
Page 32 and 33:
SPECIAL LECTURE Engineering Critica
Page 34 and 35:
Nishimura R, Ornato JP, Page RL, Ri
Page 36 and 37:
Do Vasoactive Drugs and Fluids Impr
Page 38 and 39:
Blood Transfusions are Important fo
Page 40 and 41:
Thinking Outside of the Box: A Nove
Page 42 and 43:
Nursing Forum 2 Luncheon Benchmarki
Page 44 and 45:
4. Mori K, Lee HT, Rapoport D, Drex
Page 46 and 47:
Differential Diagnosis of AKI: Can
Page 48 and 49:
Myocardial Stunning and Brain Edema
Page 50 and 51:
4. Udy A, Roberts JA, Lipman J. Wha
Page 52 and 53:
CRRT and ECMO: Techniques and Outco
Page 54 and 55:
Management of Severe Heart Failure:
Page 56 and 57:
Avoiding Anticoagulation for CRRT:
Page 58 and 59:
Improving Outcomes from</st
Page 60 and 61:
The Changing Face of AKI: Snapshots
Page 62 and 63:
Alkaline Phosphatase Peter Pickkers
Page 64 and 65:
creatinine (Cr) was measured using
Page 66 and 67:
Surveillance and Early Recognition
Page 68 and 69:
therapy admitted to general intensi
Page 70 and 71:
A01 Assessing the Microcirculation
Page 72 and 73:
A01 Assessing the Microcirculation
Page 74 and 75:
C03 Critical Care Pharmacology: Vas
Page 76 and 77:
D04 Biomarkers 1: Principles and Ap
Page 78 and 79:
6. Ferguson JW, Dover AR, Chia S, C
Page 80 and 81:
G07 Fluids and Solutions in the Cri
Page 82 and 83:
A09 Vascular Access /Membrane and C
Page 84 and 85:
A09 Vascular Access /Membrane and C
Page 86 and 87:
C11 Critical Care Management: Nutri
Page 88 and 89:
D12 Biomarkers 2: Application in AK
Page 90 and 91:
Educational Objectives: E13 Liver a
Page 92 and 93:
G15 Fluids and Solutions in the Cri
Page 94 and 95:
Educational Objectives: 1) Discuss
Page 96 and 97:
B18 Fluid Management Ravindra L. Me
Page 98 and 99:
C19 Acid Base and Electrolyte Probl
Page 100 and 101:
D20 Extracorporeal Techniques for S
Page 102 and 103:
the mediatordelivery hypothesis. In
Page 104 and 105:
F22 Ensuring Patient Safety and Qua
Page 106 and 107:
H24 Patient Centered Care in the IC
Page 108 and 109:
B26 Starting and Stopping RRT for A
Page 110 and 111:
C27 Acid Base and Electrolyte Probl
Page 112 and 113:
D28 Extracorporeal Techniques for S
Page 114 and 115:
E29 Heart Failure and Cardio-Renal
Page 116 and 117:
F30 Ensuring Patient Safety and Qua
Page 118 and 119: H32 Withdrawing & Withholding Suppo
Page 120 and 121: Patel SS, Holley JL. Withholding an
Page 122 and 123: ABSTRACTS FROM 17
show all

ABSTRACTS from 16th International COnference on ... - CRRT Online

Create successful ePaper yourself

Delete template?

Save as template?